MedTrace Logo

Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch

NCT06680778 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 175

Last updated 2025-08-13

No results posted yet for this study

Summary

The goal of this single center prospective observational study is to determine the effect of chemotherapy on (the change in) vital parameters. The main question it aims to answer are: Can changes in vital parameters be measured by using a Fitbit in patients with cancer while undergoing chemotherapy. Participants will be asked to wear a Fitbit for the first two cycles of chemotherapy to evaluate the changes in vital parameters.

Conditions

Interventions

DEVICE

Proactive Monitoring

Proactive monitoring of vital signs for the duration of the first two cycles of chemotherapy by using a Fitbit

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2025-11-01
Completion
2025-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06680778 on ClinicalTrials.gov